Temperature impact on [68Ga]Ga-edotreotide for the shipping of radioactive material in shielded container

Camille Schmitt, Julien Fouque, S. Blondeel-Gomes, Claire Provost, Emilie Da Costa Branquinho, Olivier Madar
{"title":"Temperature impact on [68Ga]Ga-edotreotide for the shipping of radioactive material in shielded container","authors":"Camille Schmitt, Julien Fouque, S. Blondeel-Gomes, Claire Provost, Emilie Da Costa Branquinho, Olivier Madar","doi":"10.1515/pthp-2020-0007","DOIUrl":null,"url":null,"abstract":"Abstract Introduction To reduce costs of gallium-68 activity in nuclear medicine, a subcontracting activity has been settled for [68Ga]Ga-edotreotide preparations. Cold kits are radiolabeled in our radiopharmacy and shipped out to nearby hospitals. According to the Summary of Product Characteristics (SmPC), preparations must be stored below 25 °C until expiration (4 h). Objective The aim of this study was to define the impact of high temperature on preparation quality during shipping. Materials & methods After radiolabeling, vials were placed in “type A” package until their expiry date. Four kits were stored in “Type A” container exposed to an outside temperature of 50 °C to represent extreme temperature conditions and one kit was kept at room temperature and used as a control. For each preparation, pH, organoleptic properties and radiochemical purity (RCP) were evaluated. RCP was measured using two radio thin layer chromatography, to evaluate the rates of gallium-68 colloids and free gallium-68. Samples were withdrawn at the end of preparation (t0), at t0 + 1 h or at t0 + 2 h and at t0 + 4 h. Results RCPs and pH of the radiopharmaceutical were all conform from t0 to t0 + 4 h. Four hours storage in “type A” package at 50 °C does not show any impact on physical and chemical quality of the preparation. Thanks to it expanded polyethylene foam which absorbs impacts; “Type A” package might acts as thermal barrier and enables the temperature regulation of shipped vials. Conclusion A monitored expedition in temperature-controlled vehicle does not seem necessary in those conditions.","PeriodicalId":19802,"journal":{"name":"Pharmaceutical Technology in Hospital Pharmacy","volume":"24 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Technology in Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/pthp-2020-0007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Introduction To reduce costs of gallium-68 activity in nuclear medicine, a subcontracting activity has been settled for [68Ga]Ga-edotreotide preparations. Cold kits are radiolabeled in our radiopharmacy and shipped out to nearby hospitals. According to the Summary of Product Characteristics (SmPC), preparations must be stored below 25 °C until expiration (4 h). Objective The aim of this study was to define the impact of high temperature on preparation quality during shipping. Materials & methods After radiolabeling, vials were placed in “type A” package until their expiry date. Four kits were stored in “Type A” container exposed to an outside temperature of 50 °C to represent extreme temperature conditions and one kit was kept at room temperature and used as a control. For each preparation, pH, organoleptic properties and radiochemical purity (RCP) were evaluated. RCP was measured using two radio thin layer chromatography, to evaluate the rates of gallium-68 colloids and free gallium-68. Samples were withdrawn at the end of preparation (t0), at t0 + 1 h or at t0 + 2 h and at t0 + 4 h. Results RCPs and pH of the radiopharmaceutical were all conform from t0 to t0 + 4 h. Four hours storage in “type A” package at 50 °C does not show any impact on physical and chemical quality of the preparation. Thanks to it expanded polyethylene foam which absorbs impacts; “Type A” package might acts as thermal barrier and enables the temperature regulation of shipped vials. Conclusion A monitored expedition in temperature-controlled vehicle does not seem necessary in those conditions.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
温度对[68Ga]Ga-edotreotide在屏蔽容器中运输放射性物质的影响
为了降低核医学中镓-68活性的成本,已经确定了[68Ga]Ga-edotreotide制剂的分包活动。冷包在我们的放射药房贴上放射性标签,然后运往附近的医院。根据产品特性概要(SmPC),制剂必须在25°C以下保存至到期(4小时)。目的研究运输过程中高温对制剂质量的影响。材料和方法放射性标签后,小瓶放置在“A型”包装中,直到有效日期。4个试剂盒储存在“A型”容器中,暴露在50°C的外部温度下,以代表极端温度条件,一个试剂盒保存在室温下,作为对照。对每种制剂的pH、感官性质和放射化学纯度(RCP)进行了评估。RCP采用两种放射性薄层色谱法测量,以评估镓-68胶体和游离镓-68的速率。在制备结束(t0)、t0 + 1 h、t0 + 2 h和t0 + 4 h时取样。结果rcp和pH值在t0 ~ t0 + 4 h期间均符合要求,在50℃条件下A型包装保存4小时,对制剂的理化质量无影响。由于它的膨胀聚乙烯泡沫吸收冲击;“A型”包装可以作为热障,使运输小瓶的温度调节。结论在这些条件下,在温控车辆中进行监测探险似乎是不必要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
7
审稿时长
12 weeks
期刊最新文献
Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL) Physicochemical stability of durvalumab (Imfinzi®) concentrate for solution in original vials after first opening Semi-automatic COVID-19 vaccine preparation for upscaling of vaccination: a descriptive study Assessment of the relevance of osmolality measurement as a criterion for the stability of solutions Use of a liquid chromatography-tandem mass spectrometry method to assess the concentration of epinephrine, norepinephrine, and phenylephrine stored in plastic syringes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1